FDA — authorised 31 July 1973
- Status: approved
FDA authorised Metaproterenol on 31 July 1973
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 31 July 1973.
Marketing authorisation holder not available in our data.